NO20016266L - Vedvarende frigivende doseringsformenhet med lateksbelegg og fremgangsmåte ved tilvirkning av samme - Google Patents

Vedvarende frigivende doseringsformenhet med lateksbelegg og fremgangsmåte ved tilvirkning av samme

Info

Publication number
NO20016266L
NO20016266L NO20016266A NO20016266A NO20016266L NO 20016266 L NO20016266 L NO 20016266L NO 20016266 A NO20016266 A NO 20016266A NO 20016266 A NO20016266 A NO 20016266A NO 20016266 L NO20016266 L NO 20016266L
Authority
NO
Norway
Prior art keywords
dosage form
form unit
latex coating
core
agent
Prior art date
Application number
NO20016266A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016266D0 (no
Inventor
Terry B Mazer
Joseph Edward Walton
Barbara S Arnholt
Monty L Evans
Ronita K Geckle
Daniel Hamilton
Jr John J Kropczynski
Franka A Murawski
Larry G Tucker
Sherri A Walker
Michael V Walsh
Ronda E Walsh
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20016266D0 publication Critical patent/NO20016266D0/no
Publication of NO20016266L publication Critical patent/NO20016266L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Moulding By Coating Moulds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20016266A 1999-07-01 2001-12-20 Vedvarende frigivende doseringsformenhet med lateksbelegg og fremgangsmåte ved tilvirkning av samme NO20016266L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/345,915 US6251432B1 (en) 1999-07-01 1999-07-01 Sustained release dosage form unit having latex coating and method of making the same
PCT/US2000/017796 WO2001001966A2 (fr) 1999-07-01 2000-06-28 Forme posologique a liberation continue a enrobage de latex et son procede de realisation

Publications (2)

Publication Number Publication Date
NO20016266D0 NO20016266D0 (no) 2001-12-20
NO20016266L true NO20016266L (no) 2002-02-27

Family

ID=23357076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016266A NO20016266L (no) 1999-07-01 2001-12-20 Vedvarende frigivende doseringsformenhet med lateksbelegg og fremgangsmåte ved tilvirkning av samme

Country Status (12)

Country Link
US (2) US6251432B1 (fr)
EP (2) EP1579853A2 (fr)
JP (2) JP4970680B2 (fr)
AT (1) ATE303796T1 (fr)
AU (1) AU774671B2 (fr)
CA (1) CA2375085A1 (fr)
DE (1) DE60022507T2 (fr)
ES (1) ES2248094T3 (fr)
MX (1) MXPA01013386A (fr)
NO (1) NO20016266L (fr)
NZ (1) NZ515756A (fr)
WO (1) WO2001001966A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002085335A1 (fr) * 2001-04-18 2002-10-31 Nostrum Pharmaceuticals Inc. Nouvel enrobage de composition pharmaceutique a liberation lente
WO2004112756A1 (fr) 2003-06-26 2004-12-29 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
US7051606B2 (en) * 2004-01-30 2006-05-30 Andrx Labs Llc Dosage form holder device and methods for immersion testing
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN104825397A (zh) * 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US8523837B2 (en) 2008-10-14 2013-09-03 Mead Johnson Nutrition Company Nutritive substance delivery container
US8801688B2 (en) * 2008-10-14 2014-08-12 Mead Johnson Nutrition Company Nutritive substance delivery container
TWI565418B (zh) * 2012-02-22 2017-01-11 Terumo Corp Semi - solid nutrition for gastric stoma

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3993073A (en) 1969-04-01 1976-11-23 Alza Corporation Novel drug delivery device
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3760984A (en) 1971-09-29 1973-09-25 Alza Corp Osmotically powered agent dispensing device with filling means
US3948254A (en) 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US3921636A (en) 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US4177256A (en) 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4968507A (en) * 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
US4874365A (en) * 1984-10-11 1989-10-17 Baxter International Inc. Feeding tube facilitating improved placement and permitting subsequent delivery of a second prescribed product and method therefor
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4838862A (en) 1986-08-04 1989-06-13 Pharmetrix Corp. Portable controlled release osmotic infusion device
US4832690A (en) 1987-01-23 1989-05-23 Baxter International Inc. Needle-pierceable cartridge for drug delivery
US4927411A (en) 1987-05-01 1990-05-22 Abbott Laboratories Drive mechanism for disposable fluid infusion pumping cassette
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
IL95423A (en) * 1989-09-21 1994-11-11 American Cyanamid Co Pulsatile once-a-day delivery systems for minocycline
US4983399A (en) 1989-10-18 1991-01-08 Eastman Kodak Company Direct compression carrier composition
US5126146A (en) 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
JP3078859B2 (ja) * 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
US5324280A (en) 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5443459A (en) 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
WO1993002558A1 (fr) 1991-08-01 1993-02-18 Biogaia Biologics Ab Procede et formulation servant a reduire des populations microbiennes
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5160742A (en) 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5221278A (en) 1992-03-12 1993-06-22 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
US5358721A (en) 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
SK279684B6 (sk) * 1993-06-14 1999-02-11 Janssen Pharmaceutica N.V. Tableta a spôsob jej výroby
US5451409A (en) 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5533973A (en) 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US5531681A (en) 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5531734A (en) 1995-01-13 1996-07-02 Abbott Laboratories Method of altering composition of nutritional product during enteral tube feeding
US5549550A (en) * 1995-01-13 1996-08-27 Abbott Laboratories Method of adding marker dye to nutritional product during enteral tube feeding
US5531682A (en) 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for adding marker dye to nutritional product during enternal tube feeding
IL118932A0 (en) 1996-07-24 1996-10-31 Dexcel Ltd Controlled release tablets

Also Published As

Publication number Publication date
AU6057400A (en) 2001-01-22
DE60022507T2 (de) 2006-07-13
US6620434B2 (en) 2003-09-16
EP1191925B1 (fr) 2005-09-07
EP1579853A2 (fr) 2005-09-28
JP4970680B2 (ja) 2012-07-11
JP2012144542A (ja) 2012-08-02
US6251432B1 (en) 2001-06-26
NO20016266D0 (no) 2001-12-20
ATE303796T1 (de) 2005-09-15
US20010024663A1 (en) 2001-09-27
EP1191925A2 (fr) 2002-04-03
JP2003503444A (ja) 2003-01-28
CA2375085A1 (fr) 2001-01-11
MXPA01013386A (es) 2002-07-22
WO2001001966A3 (fr) 2001-07-26
NZ515756A (en) 2003-08-29
WO2001001966A2 (fr) 2001-01-11
AU774671B2 (en) 2004-07-01
ES2248094T3 (es) 2006-03-16
DE60022507D1 (de) 2005-10-13

Similar Documents

Publication Publication Date Title
NO20016266D0 (no) Vedvarende frigivende doseringsformenhet med lateksbelegg og fremgangsmåte ved tilvirkning av samme
YU47422B (sh) Sredstvo sa asimetričnom membranom i postupak njenog dobijanja
ATE380541T1 (de) Herstellung von vitaminemulsionen und konzentrate davon
ATE217789T1 (de) Angenehm schmeckende pharmazeutische zusammensetzungen
WO2002055136A3 (fr) Dispositif d'administration de medicaments intravasculaire et son utilisation
JPS55153713A (en) Pharmaceutical preparation of ribosome containing active substance
KR920702618A (ko) 약제학적 제형
GB9116610D0 (en) Preparation of microparticles
NZ301681A (en) composition containing an emulsion comprising fatty acid derivatives and a compound of vegetal origin which can be used to modify the behaviour of cats
DK1117383T3 (da) Doseringsformer omfattende terapeutisk formulering
ATE143830T1 (de) Mikrokapseln mit wänden aus primären alkoholfunktionen enthaltenden polysacchariden, und zusammensetzungen daraus
ES8802115A1 (es) Procedimiento para la preparacion de formas de administracion de medicamentos solidas y duraderas a base de hidroxipropilcelulosa.
KR870002832A (ko) 제약 조성물
HK1043936A1 (zh) 含有脂调节剂的新的配方
ATE322250T1 (de) Selbstemulgierendes system zur arzneistoffabgabe von fettlöslichen wirkstoffen
EP1738754A4 (fr) Preparation pharmaceutique solide
TW200505485A (en) Sustained drug-release particles and process for producing the same
ATE326217T1 (de) Verfahren zur herstellung einer schwimmfähigen tablette mit alfuzosin
FR2845289B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques.
DE59708495D1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
WO2001001966A9 (fr) Forme posologique a liberation continue a enrobage de latex et son procede de realisation
WO2001000184A3 (fr) Combinaison d'inhibiteurs de proteine de transfert microsomale (mtp) et d'agents hypolipidemiants et leur utilisation dans des medicaments
GB2333451A (en) Use of a bolus with a differential surface coating to administer beneficial substances to ruminant animals at a uniform rate of release
MY120392A (en) A novel drug delivery system : formulation for fat-soluble drugs
GB2363394B (en) Liquid peroxide bleach formulation

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application